CIPROFLOXACIN HYDROCHLORIDE IN DEXTROSE

The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc. under contract SPE2DP26F7882 for the delivery of one package of Ciprofloxacin Hydrochloride in Dextrose, identified by NSN 6505013366179 and associated NDC codes 00409-3300-24 and 25021-0114-87, at a total price of $195.96. The award was issued on July 21, 2026, as a delivery order under the master contract SPE2DX25D9900, with delivery required by August 5, 2026, to the destination address at Joint Base Elmendorf-Richardson, Alaska. The contract specifies FOB destination terms with the contractor responsible for all transportation costs and risks, and inspection and acceptance occur solely at the delivery point. Quantity tolerance is strictly zero percent variance, meaning exact compliance with the single unit of issue is mandatory. The product is procured under NAICS code 424210, classifying the awardee as a pharmaceutical wholesaler, with no socioeconomic set-aside indicated. Payment is processed through the Defense Logistics Agency’s remit-to address in Alaska, and no electronic invoicing system is specified. The contract includes no explicit references to packaging standards such as MIL-STD-129 or MIL-STD-2073, nor are any quality specifications like USP or ASTM cited beyond adherence to unit-of-issue and DLA logistics guidelines. No formal contract clauses from FAR are listed, and there is no evidence of attachments, evaluation factors, representations, or special requirements such as security clearances or key personnel provisions. The awardee’s CAGE code is 1UNB0, and manufacturer CAGE codes are provided for the listed NDCs, but UEI and size status details are not disclosed. The contract is executed as a simple, single-line-item order under an indefinite-delivery vehicle with no options, escalation clauses, or modification numbers indicated.